2026 中的 Tirzepatide：批准的药物证据与研究用材料
为什么 FDA 批准的替西帕肽药物、复方产品和研究用途目录材料不是可互换的证据类别。
阅读源码评论 →
Research Topic
代谢与身体成分
Topic knowledge
Source-reviewed reading for metabolic & body composition
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 13–16 of 16 reviewed articles · Page 3 of 3
Tirzepatide 双 GIP/GLP-1 信令：机制和试验端点解释
An evidence-led explanation of tirzepatide dual receptor agonism and the endpoints measured in SURPASS and SURMOUNT trials, with clear limits on applying…
阅读源码评论 →如何验证 5-Amino-1MQ 研究材料：身份、纯度和批次文件
A practical laboratory guide to checking 5-Amino-1MQ identity, purity language, analytical methods and lot-specific documentation without confusing a catalog listing with a…
阅读源码评论 →5-Amino-1MQ 和 NNMT 抑制：临床前证据实际表明的内容
A source-led review of 5-Amino-1MQ as an NNMT inhibitor, separating enzyme, cell and mouse findings from claims that have not been demonstrated…
阅读源码评论 →Need a peptide for metabolic & body composition research?
If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.